ODYSSEA PHARMA

Odysea Pharma is a pharmaceutical development and production centre part of Abbvie group. Odyssea is designated as one of the groups Centre of Excellence for womens health delivering product development, GMP manufacturing of LevosertTM hormonal intra-uterine device and quality & regulatory expertise from a custom-designed facility located in Liege, Belgium. NDA approved in 2014, Odyssea Pharma is developing industrial activities with a dedicated production area to LevosertTM hormonal intra-uterine device (IUD) a flexible frame which consistently releases small quantities of levonorgestrel in the uterine cavity. With Sponsor Medicines 360 our two handed inserter Levosert is produced at industrial scale for Europe and US. Global in reach. Specialised in focus. On March 17th, 2015, Actavis (NYSE:ACT) completed the acquisition of Allergan, creating a $23 billion diversified global pharmaceutical company and a leader in a new industry model - Growth Pharma. The combined company h...